Adaptability of Cancers to Therapy
David Goodrich, PhD of Roswell Park Cancer Institute, Department of Pharmacology and Therapeutics explains the transformation of cancers into stem-cell phenotypes, which allows them to adapt to differ...
Author: aacr2017
Added: 04/27/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 27, 2017 Category: Cancer & Oncology Source Type: podcasts
Abstract Overview: Resistance to Anti-Androgen Therapy in Patients with Prostate Cancer
David Goodrich, PhD of Roswell Park Cancer Institute, Department of Pharmacology and Therapeutics gives an overview of his abstract, Rb1 suppresses prostate cancer metastasis and lineage plasticity un...
Author: aacr2017
Added: 04/27/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 27, 2017 Category: Cancer & Oncology Source Type: podcasts
& quot;Hallmarks of Cancer & quot;: Treatment Trends for 2017
David Goodrich, PhD of Roswell Park Cancer Institute, Department of Pharmacology and Therapeutics discusses the treatment trends for prostate cancer in 2017 and gives an overview of an AACR session, w...
Author: aacr2017
Added: 04/27/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 27, 2017 Category: Cancer & Oncology Source Type: podcasts
FDA Drug Safety Podcast: FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children; recommends against use in breastfeeding women
On April 20, 2017, FDA announced it is restricting the use of codeine and tramadol medicines in children. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - April 26, 2017 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
Conflating Chronic Pain Management and Opioid Abuse Potential
Are policy makers and prescribers conflating the issues of chronic pain management and opioid abuse? (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - April 14, 2017 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
FDA Drug Safety Podcast: FDA warns about increased risk of serious pancreatitis with irritable bowel drug Viberzi (eluxadoline) in patients without a gallbladder
On March 15, 2017, FDA announced it is warning that Viberzi (active ingredient eluxadoline), a medicine used to treat irritable bowel syndrome with diarrhea (IBS-D), should not be used in patients who do not have a gallbladder. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - March 22, 2017 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
FDA Drug Safety Podcast: FDA revises description of mental health side effects of stop-smoking medicines Chantix and Zyban to reflect clinical trial findings
On December 16, 2016, the FDA announced that based on our review of a large clinical trial that we required the drug companies to conduct, we have determined the risk of serious side effects on mood, behavior, or thinking with the stop-smoking medicines Chantix (active ingredient varenicline) and Zyban (active ingredient bupropion) is lower than previously suspected. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - March 9, 2017 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
FDA Drug Safety Podcast: FDA warns about rare but serious allergic reactions with the skin antiseptic chlorhexidine gluconate
On February 2, 2017, the FDA announced it is warning that rare but serious allergic reactions have been reported with the widely used skin antiseptic products containing chlorhexidine gluconate. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - March 9, 2017 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
FDA Drug Safety Podcast: Updated FDA review concludes that use of pioglitazone may be linked to an increased risk of bladder cancer
On December 12, 2016, FDA announced as a result of an updated review, that it has concluded that use of the type 2 diabetes medicine pioglitazone (brand names Actos, Actoplus Met, Actoplus Met XR, Duetact, Oseni) may be linked to an increased risk of bladder cancer. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - March 9, 2017 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
FDA Drug Safety Podcast: FDA review results in new warnings about using general anesthetics and sedation drugs in young children and pregnant women
On December 14, 2016, FDA is warning that repeated or lengthy use of general anesthetic and sedation drugs during surgeries or procedures in children younger than 3 years or in pregnant women during their third trimester may affect the development of children ’s brains. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - March 9, 2017 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
Emerging Drug-Resistant Gonorrhea: What's New and What Now?
We are starting to lose our last line of defense against drug-resistant gonorrhea. What can be done? (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - March 6, 2017 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
Menopausal Hormone Therapy and Alzheimer Disease Risk
Dr Andrew Kaunitz describes results of a recent population-based study that supports the ' critical window ' hypothesis of hormone therapy after menopause. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - February 28, 2017 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
How Menopausal Hormone Therapy Could Reduce Alzheimer's Risk
Dr Andrew Kaunitz describes results of a recent population-based study that supports the ' critical window ' hypothesis of hormone therapy after menopause. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - February 28, 2017 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
GLP-1 Receptor Agonists and Insulin: A Synergistic Choice
Drs Shubrook and Skolnik discuss the role of GLP-1 receptor agonists in the management of type 2 diabetes and the surprising benefits of these agents when combined with insulin. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - February 10, 2017 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
